Skin drug may hold key to type 1 diabetes treatment
London: A drug, Alefacept, which is used for treating skin disorder, Psoriasis, has shown promising results for treating some aspects of type 1 diabetes.
A small trial on US patients suggests that it can help body produce its own insulin, the BBC reported.
Alefacept (sold as Amevive) was used to treat the skin disorder, psoriasis, in the US before being withdrawn by its manufacturer in 2011; it was never approved for the European drug market.
In the trial, weekly injections were given to 33 patients for 12 weeks, followed by a break of 12 weeks, and then another 12 weekly doses, another 16 participants were given placebos following the same schedule.
The researchers found 'significant differences' between the two groups four hours after eating, the group receiving the drug showed that they were able to preserve insulin while the placebo taking group's insulin levels went down.
After 1 year, the same group showed no significant increase raise in insulin use, yet those in the placebo group did.
The findings have been published in The Lancet Diabetes and Endocrinology.
More from India
More from World
More from Sports
More from Entertaiment
- Sunanda Pushkar murder case: Police may approach court seeking lie detector test on Shashi Tharoor
- Jayalalithaa wins big in RK Nagar by-poll, defeats CPI's Mahendran by over 1.5 lakh votes
- Check JEE (Main) 2015 rank on www.jeemain.nic.in, cbseresults.nic.in
- Jawaharlal Nehru's Wikipedia page edited from govt IP address; Congress seeks PM Modi's reply
- After Pankaja Munde, now Vinod Tawde accused of irregularities in awarding contracts in Maharashtra